• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, September 2, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Scientists uncover possible therapeutic targets for rare autism spectrum disorder

Bioengineer by Bioengineer
January 30, 2017
in Science News
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Researchers have uncovered 30 genes that could, one day, serve as therapeutic targets to reverse Rett syndrome, a rare neurological disorder that affects only girls and is a severe form of an autism spectrum disorder.

The study, led by scientists at Fred Hutchinson Cancer Research Center in Seattle, will be published January 30 in the Proceedings of the National Academy of Sciences.

There are currently no treatments specific to Rett syndrome, which affects approximately 15,000 girls and women in the U.S. and 350,000 around the world. Girls with Rett syndrome are born healthy and seem like any other baby up to one or two years of age. But then they start missing milestones and backslide in development.

"They have this period of normal development, and then it's taken away from them," said Dr. Antonio Bedalov, who led the study and is a clinical researcher at Fred Hutch. "It's devastating for the families."

The disorder is tied to a genetic defect in the MeCP2 gene, which is carried on the X chromosome. Girls, of course, have two copies of this chromosome but one X is silenced in every cell. Even though, on average, half of a girl's cells will produce the healthy version of this X-linked gene, the mutation in the other half of cells is enough to trigger the symptoms of the disorder.

Using adult mouse cells in the lab, Bedalov and his colleagues identified a way to partially reawaken the "inactive X," the X chromosome that is silenced in every cell. The researchers were also able to reactivate the normal copy of the MeCP2 gene.

Bedalov emphasized that the findings are still in the preclinical stage and that therapeutics are a long ways off.

But it's a start, Bedalov said. Because their approach leads to the reactivation of the entire chromosome, it could also apply to other, similar disorders that involve the X chromosome.

###

The Rett Syndrome Research Trust funded the project.

At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch's pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer with minimal side effects. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation's first and largest cancer prevention research program, as well as the clinical coordinating center of the Women's Health Initiative and the international headquarters of the HIV Vaccine Trials Network. Private contributions are essential for enabling Fred Hutch scientists to explore novel research opportunities that lead to important medical breakthroughs. For more information visit fredhutch.org or follow Fred Hutch on Facebook, Twitter or YouTube.

Media Contact

Molly McElroy
[email protected]
206-667-6651
@FredHutch

http://www.fredhutch.org

############

Story Source: Materials provided by Scienmag

Share12Tweet8Share2ShareShareShare2

Related Posts

Fluorine “Forever Chemical” in Medicines Does Not Increase Drug Reaction Risks

Fluorine “Forever Chemical” in Medicines Does Not Increase Drug Reaction Risks

September 2, 2025

Scientists Reveal Link Between Gut Fungi, Human Genetics, and Disease Susceptibility

September 2, 2025

Ultrasound Advances Boost Prenatal Heart Defect Detection, Though Regional Disparities Persist

September 2, 2025

Combining Sterile Insects and Fungi to Combat Drosophila

September 2, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    154 shares
    Share 62 Tweet 39
  • Molecules in Focus: Capturing the Timeless Dance of Particles

    143 shares
    Share 57 Tweet 36
  • Needlestick Injury Rates in Nurses and Students in Pakistan

    123 shares
    Share 49 Tweet 31
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    117 shares
    Share 47 Tweet 29

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Fluorine “Forever Chemical” in Medicines Does Not Increase Drug Reaction Risks

Scientists Reveal Link Between Gut Fungi, Human Genetics, and Disease Susceptibility

Ultrasound Advances Boost Prenatal Heart Defect Detection, Though Regional Disparities Persist

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.